Pfizer Inc (PFE.HA)
Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
At close: 08:00AM CEST
| Previous close | 26.29 |
| Open | 26.11 |
| Bid | 26.00 x 0 |
| Ask | 26.02 x 0 |
| Day's range | 26.11 - 26.11 |
| 52-week range | 23.64 - 37.35 |
| Volume | |
| Avg. volume | 77 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Yahoo FinanceNovavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
ZacksPharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
GuruFocus.comDecoding Pfizer Inc (PFE): A Strategic SWOT Insight
Insightful Analysis of Pfizer Inc's Financial Health and Strategic Position
© 2024 Yahoo. All rights reserved.